BIO - Bio-Rad Laboratories Inc.
(NaN%)
SNP 500
Buy
Strong Growth and Improving●Stock Price Attractive
87%
based on last 5 year data.
Income Statement is STRONG
Revenue Growth is 15.95%
Operating Income Growth is 76.8%
Net Income Growth is 159.45%
Earnings Per Share (EPS) Growth is 160.45%
Net Margin is 151.73%
Balance Sheet is STRONG
Current Asset to Current Liability Ratio is 3.57
Debt Ratio is 0.24
Current Debt to Net Income Ratio is 0.0
Total Debt to Total Assets Ratio is 0.0
Cash Flow is STRONG
Cash from Operations Growth is 31.05%
Capital Expenditure is Low
Net Increase in Cash is Positive
Long Term Score Trend is POSITIVE
Investment Risk is Low
based on last 4 quarter data.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
Bio-Rad Laboratories Inc. (BIO) - www.bio-rad.com
Bio-Rad Laboratories, Inc. is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for over 65 years, its products advance the discovery process and improve healthcare. Bio-Rad's customers are university and research institutions, hospitals, public health and commercial laboratories, biotechnology and pharmaceutical companies, as well as applied laboratories that include food safety and environmental quality. Founded in 1952, Bio-Rad is based in Hercules, California, and has a global network of operations with more than 7,800 employees worldwide. Bio-Rad had revenues exceeding $2.5 billion in 2020.Exchange - NEW YORK STOCK EXCHANGE, INC.
Industry - Analytical Laboratory Instrument Manufacturing
Sector - Manufacturing
CEO -
Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2021 and future.
Know the Stock © 2021 and future.